Streetbeat News

Stock Prices

CASS

Cass Information Sys (NASDAQ:CASS) reported Q4 earnings with an EPS of $0.61, beating estimates by 27.08% against the expected $0.48. Revenue increased by $1.79 million compared to the same period last year. Despite missing EPS estimates last quarter by $0.01, resulting in a 1.48% share price drop the following day, the company has shown improved performance this quarter.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 2:30 pm

ESQ

Esquire Financial Holdings (NASDAQ:ESQ) reported Q4 earnings with an EPS of $1.18, surpassing the estimate of $1.15 by 2.61%. Revenue increased by $3.81 million compared to the same period last year. The company had previously beaten EPS estimates in Q3 2023, which resulted in a slight 0.02% share price increase the following day.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 2:30 pm

NOK

Nokia's stock price is on the rise following the announcement of their Q4 financial results, indicating a positive reception from investors.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:28 pm

RMD

ResMed Inc. (RMD) shares have risen following the announcement of their Q2 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:27 pm

BX

Blackstone Inc (NYSE:BX) shares rose after reporting Q4 FY23 results. Despite missing revenue estimates with $2.54 billion against a $2.57 billion consensus, distributable earnings increased 4% Y/Y to $1.39 billion. Fee-related earnings varied across segments, with a decline in Private Equity. Net accrued performance revenue decreased from the prior year, but distributable EPS of $1.11 beat the $0.95 consensus. AUM grew 7% Y/Y to $1.04 trillion. Blackstone announced a dividend of $0.94/share and repurchased 0.4 million shares. The stock is up 3.04% premarket.

Portfolio Pulse from Lekha Gupta

January 25, 2024 | 2:27 pm

PFE

Pfizer Inc (NYSE:PFE) is expected to report a Q4 2023 EPS loss of $(0.22) and revenues of $14.25 billion. The company's FY24 revenue forecast includes contributions from the Seagen acquisition, with adjusted EPS guidance lower than consensus. Pfizer's obesity drug trial showed efficacy but had high dropout rates due to side effects. Additionally, a former Pfizer employee was convicted of securities fraud. PFE shares dropped 1.69% in premarket trading.

Portfolio Pulse from Vandana Singh

January 25, 2024 | 2:26 pm

COLB

Stephens & Co. analyst Andrew Terrell downgraded Columbia Banking System (NASDAQ:COLB) from Overweight to Equal-Weight and set a price target of $24.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:26 pm

BA

B of A Securities analyst Ronald Epstein has downgraded Boeing (NYSE:BA) from Buy to Neutral and reduced the price target from $255 to $225.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:24 pm

AAPL

AI

AMD

AMZN

INTC

NFLX

NVDA

PYPL

QQQ

TSLA

Swaggy Stocks has listed the top 10 trending stocks on WallStreetBets as of January 25, 2024. The stocks include TSLA, NVDA, AMD, AI, PYPL, NFLX, INTC, QQQ, AAPL, and AMZN.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:23 pm

TSLA

Goldman Sachs analyst Mark Delaney has maintained a Neutral rating on Tesla (NASDAQ:TSLA) but has reduced the price target from $255 to $220.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:22 pm